KALV — Kalvista Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Kalvista Pharmaceuticals, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th	2024 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	67.7	249	166	149	210
Net Total Receivables	16.5	10.4	14.1	18.6	10.9
Prepaid Expenses
Total Current Assets	88.7	264	194	172	226
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.65	7.55	10	10.8	9.15
Other Long Term Assets
Total Assets	92.5	272	204	183	235
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.72	9.77	11.6	15	22.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.78	14.8	18.8	22.2	28.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	83.8	257	185	161	207
Total Liabilities & Shareholders' Equity	92.5	272	204	183	235
Total Common Shares Outstanding